University of North Carolina - Chapel Hill Endowment Fund

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website

Clinical Trials

Accelerated Invisalign Therapy in Conjunction With Acceledent Aura

Not Applicable

Completed

Conditions: Malocclusion

Interventions: Device: AcceleDent Aura
Device: Accelerated Invisalign therapy

First Posted Date: 2016-08-16

Last Posted Date: 2020-01-27

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 34

Registration Number: NCT02868554

Locations: 🇺🇸
UNC Department of Orthodontics, Chapel Hill, North Carolina, United States

Human Biological Responses to Low Level Ozone

Not Applicable

Completed

Conditions: Environmental Exposure
Nasal Inflammation

Interventions: Other: Ozone
Other: Filtered Air
Device: Health and Exposure Tracker (HET)

First Posted Date: 2016-08-05

Last Posted Date: 2021-05-14

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 15

Registration Number: NCT02857283

Locations: 🇺🇸
Center for Environmental Medicine, Asthma and Lung Biology, Chapel Hill, North Carolina, United States

Move, Play, Learn! Creating Active Classrooms in Early Care and Education Centers

Not Applicable

Completed

Conditions: Motor Activity

Interventions: Behavioral: Move, Play, Learn!

First Posted Date: 2016-08-01

Last Posted Date: 2017-09-14

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 208

Registration Number: NCT02851030

Geniculate Artery Embolization for the Treatment of Knee Pain

Not Applicable

Completed

Conditions: Osteoarthritis Of Knee

Interventions: Device: Geniculate Artery Embolization

First Posted Date: 2016-07-29

Last Posted Date: 2019-08-20

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 20

Registration Number: NCT02850068

Locations: 🇺🇸
Vascular Institute of Virginia, Woodbridge, Virginia, United States
🇺🇸
UNC Hospitals, Chapel Hill, North Carolina, United States

Systemic Inflammatory Response to CCRE

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: CCRE

First Posted Date: 2016-07-28

Last Posted Date: 2019-09-20

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 25

Registration Number: NCT02847247

Locations: 🇺🇸
Environmental Protection Agency Human Studies facility, Chapel Hill, North Carolina, United States

A Volumetric Analysis of Soft and Hard Tissue Healing for Ridge Preservation and Socket Seal After Tooth Extraction

Not Applicable

Completed

Conditions: Tooth Extraction

Interventions: Device: Xenograft bone substitute
Device: Collagen dressing
Device: 3D-collagen matrix

First Posted Date: 2016-07-26

Last Posted Date: 2019-02-06

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 24

Registration Number: NCT02844569

Locations: 🇺🇸
General & Oral Health Center, Chapel Hill, North Carolina, United States

An Open Label Trial of Bupropion and Naltrexone for Binge Drinking

Phase 2

Completed

Conditions: Binge Drinking

Interventions: Drug: Naltrexone
Drug: Bupropion

First Posted Date: 2016-07-22

Last Posted Date: 2018-12-26

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 12

Registration Number: NCT02842073

Locations: 🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Teriflunomide's Therapeutic Mechanisms of Action in Patients With Relapsing Remitting Multiple Sclerosis.

Terminated

Conditions: RELAPSING REMITTING MULTIPLE SCLEROSIS

First Posted Date: 2016-07-14

Last Posted Date: 2017-09-15

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 26

Registration Number: NCT02833714

Locations: 🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

North Carolina Newborn Exome Sequencing for Universal Screening

Not Applicable

Completed

Conditions: Metabolism, Inborn Errors
Hereditary Disease
Hearing Loss

Interventions: Genetic: Diagnosed, whole exome sequencing
Genetic: Well infant, whole exome sequencing

First Posted Date: 2016-07-11

Last Posted Date: 2020-07-08

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 106

Registration Number: NCT02826694

Locations: 🇺🇸
UNC Hospitals, Chapel Hill, North Carolina, United States

Feasibility Study of Retinal Screening Using the RetinaVue 100 Camera in Outpatient Dialysis Centers

Not Applicable

Completed

Conditions: Diabetic Retinopathy
Eye Diseases
Kidney Failure, Chronic

Interventions: Device: RetinaVue 100 camera

First Posted Date: 2016-07-06

Last Posted Date: 2018-07-20

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 68

Registration Number: NCT02823600

Locations: 🇺🇸
UNC Ophthalmology, Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy